131 related articles for article (PubMed ID: 38144521)
1. The prognostic value of zonal origin in clinically localized prostate cancer: a systematic review and meta-analysis.
Jin S; Wu L; Liang Z; Yan W
Front Oncol; 2023; 13():1248222. PubMed ID: 38144521
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Obesity and biochemical recurrence in clinically localised prostate cancer: a systematic review and meta-analysis of 86,490 patients.
Rivera-Izquierdo M; Pérez de Rojas J; Martínez-Ruiz V; Arrabal-Polo MÁ; Pérez-Gómez B; Jiménez-Moleón JJ
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):411-421. PubMed ID: 34987170
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancers of different zonal origin: clinicopathological characteristics and biochemical outcome after radical prostatectomy.
Iremashvili V; Pelaez L; Jordá M; Manoharan M; Rosenberg DL; Soloway MS
Urology; 2012 Nov; 80(5):1063-9. PubMed ID: 23107397
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.
Van den Broeck T; van den Bergh RCN; Arfi N; Gross T; Moris L; Briers E; Cumberbatch M; De Santis M; Tilki D; Fanti S; Fossati N; Gillessen S; Grummet JP; Henry AM; Lardas M; Liew M; Rouvière O; Pecanka J; Mason MD; Schoots IG; van Der Kwast TH; van Der Poel HG; Wiegel T; Willemse PM; Yuan Y; Lam TB; Cornford P; Mottet N
Eur Urol; 2019 Jun; 75(6):967-987. PubMed ID: 30342843
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy.
Takamatsu K; Matsumoto K; Shojo K; Tanaka N; Takeda T; Morita S; Kosaka T; Mizuno R; Shinojima T; Kikuchi E; Asanuma H; Oya M
Urol Oncol; 2019 Sep; 37(9):575.e19-575.e25. PubMed ID: 30967332
[TBL] [Abstract][Full Text] [Related]
7. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence.
O'Neil LM; Walsh S; Cohen RJ; Lee S
BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868
[TBL] [Abstract][Full Text] [Related]
8. Different predictive values of microvessel density for biochemical recurrence among different PCa populations: A systematic review and meta-analysis.
Jiang J; Li J; Xiong X; Zhang S; Tan D; Yang L; Wei Q
Cancer Med; 2023 Feb; 12(3):2166-2178. PubMed ID: 35933720
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionation for clinically localized prostate cancer.
Hickey BE; James ML; Daly T; Soh FY; Jeffery M
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011462. PubMed ID: 31476800
[TBL] [Abstract][Full Text] [Related]
10. Diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis.
Hua Q; Zhu Y; Liu H; Ye X
Int Urol Nephrol; 2016 Sep; 48(9):1437-43. PubMed ID: 27170341
[TBL] [Abstract][Full Text] [Related]
11. Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
Chun FK; Briganti A; Jeldres C; Erbersdobler A; Schlomm T; Steuber T; Gallina A; Walz J; Perrotte P; Huland H; Graefen M; Karakiewicz PI
Eur Urol; 2007 Apr; 51(4):949-55; discussion 955. PubMed ID: 16904818
[TBL] [Abstract][Full Text] [Related]
12. Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
Raval AD; Thakker D; Negi H; Vyas A; Kaur H; Salkini MW
Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):151-62. PubMed ID: 26782711
[TBL] [Abstract][Full Text] [Related]
13. Obesity has multifaceted impact on biochemical recurrence of prostate cancer: a dose-response meta-analysis of 36,927 patients.
Hu MB; Xu H; Bai PD; Jiang HW; Ding Q
Med Oncol; 2014 Feb; 31(2):829. PubMed ID: 24390417
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
[TBL] [Abstract][Full Text] [Related]
15. Retzius-sparing versus standard robotic-assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.
Rosenberg JE; Jung JH; Edgerton Z; Lee H; Lee S; Bakker CJ; Dahm P
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013641. PubMed ID: 32813279
[TBL] [Abstract][Full Text] [Related]
16. Intake of Non-steroidal Anti-inflammatory Drugs and the Risk of Prostate Cancer: A Meta-Analysis.
Shang Z; Wang X; Yan H; Cui B; Wang Q; Wu J; Cui X; Li J; Ou T; Yang K
Front Oncol; 2018; 8():437. PubMed ID: 30406025
[No Abstract] [Full Text] [Related]
17. An Up-to-date Meta-analysis of Coffee Consumption and Risk of Prostate Cancer.
Xia J; Chen J; Xue JX; Yang J; Wang ZJ
Urol J; 2017 Aug; 14(5):4079-4088. PubMed ID: 28853102
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the CAPRA clinical prediction rule: a systematic review and meta-analysis.
Meurs P; Galvin R; Fanning DM; Fahey T
BJU Int; 2013 Mar; 111(3):427-36. PubMed ID: 22882877
[TBL] [Abstract][Full Text] [Related]
19. Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.
Hamada R; Nakashima J; Ohori M; Ohno Y; Komori O; Yoshioka K; Tachibana M
Int J Clin Oncol; 2016 Jun; 21(3):595-600. PubMed ID: 26585896
[TBL] [Abstract][Full Text] [Related]
20. Impact of family history on oncological outcomes in primary therapy for localized prostate cancer patients: a systematic review and meta-analysis.
Urabe F; Kimura S; Yamamoto S; Tashiro K; Kimura T; Egawa S
Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):638-646. PubMed ID: 33589769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
